Completed PHASE1 INTERVENTIONAL 1-arm NCT01853423

Tuberous Sclerosis Complex: Facial Angiofibroma Skin Cream

Sponsor: Le Bonheur Children's Hospital

Interventions Rapamune

Updated 7 times since 2017 Last updated: Aug 17, 2016 Started: Oct 31, 2013 Primary completion: May 31, 2016 Completion: Jul 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01853423, this PHASE1 trial focuses on Facial Angiofibroma and remains completed. Sponsored by Le Bonheur Children's Hospital, it has been updated 7 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Mar 2023 — Jul 2024 [monthly]

Completed PHASE1
Jan 2021 — Mar 2023 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE1
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1

First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Le Bonheur Children's Hospital
Pfizer
University of Tennessee

Data source: Le Bonheur Children's Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Memphis, United States